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Quantitative Assessment of Synovial
Vascularity Using Contrast-Enhanced
Power Doppler Ultrasonography:
Correlation with Histologic Findings and
MR Imaging Findings in Arthritic Rabbit
Knee Model
Objective: To validate contrast-enhanced power Doppler ultrasonography (PD
US) for the evaluation of synovial vascularity in an arthritic rabbit knee model in
correlation with MR and histological findings.
Materials and Methods: Power Doppler ultrasonography was performed for
carrageenin-induced arthritic left knee and control right knee of 13 rabbits, first
without and then with sonic contrast agent enhancement (Levovist, Schering,
Berlin Germany), followed by gadolinium-enhanced MR imaging. Synovial vascu-
larity was quantitatively assessed by calculating the color pixel area in power
Doppler sonography using a computer-aided image analysis program and by
grading the enhancement on MR images: grade 1, enhancement of knee joint is
less than one-third of the area; grade 2, one-third to two-thirds enhancement; and
grade 3, more than two-thirds enhancement. Microvessel density (MVD) was
measured on slides stained immunohistochemically for CD31 antigen for histo-
logical assessment.
Results: The mean area of color pixels in PD US changed from 4.37 to 16.42
mm2 in the arthritic knee after enhancement (p < 0.05), whereas it changed from
0.77 to 2.31 mm2 in the control knee (p < 0.05). Arthritic knees had greater power
Doppler signal than control knees both before and after contrast administration (p
< 0.05). The average MVD was 88 in arthritic knees and 46 in control knees.
MVDs correlated with color pixel areas of contrast-enhanced power Doppler
imaging in arthritic knees. In MR grading of arthritic knees, five were grade 2 and
eight were grade 3. MVD and PD US revealed no significant difference between
grade 2 and 3 arthritic knees (p > 0.05).
Conclusion: Sonic contrast-enhanced PD US improves the visualization of
synovial vascularity and allows quantitative measurement in experimentally
induced rabbit arthritic knees.
ynovitis is sometimes overlooked in clinically silent, asymptomatic
patients with early arthritis (1). American College of Rheumatology
(ACR) criteria for the diagnosis of rheumatoid arthritis (RA) have been
used widely, but these criteria are not sufficiently effective for detecting early RA (2,
3). Synovial biopsy may reveal the typical histologic features of RA, but it does not
provide specific features for RA and is rarely used because of its invasiveness (4).
However, early diagnosis of RA is considered an important issue in order to prevent
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joint deformity and disability. 
Regarding the imaging strategy, ultrasonography (US)
and magnetic resonance imaging (MRI) both have an
increasing role in the early detection and follow-up in RA
because of their quantitative measurement capabilities (5,
6). Enhanced MR imaging is more informative than
conventional MR imaging. Power Doppler ultrasonogra-
phy (PD US) has also been useful for evaluating synovial
vascularity (7 12). Synovial hyperemia is mostly
accompanied by increased vascularity in RA, and the
progression or regression of alterations in vascularity can
be monitored during therapeutic follow-up. Regardless of
the PD US application, synovitis can barely be depicted in
cases with mildly increased vascularity. To improve
Doppler sensitivity, an US contrast agent has been
introduced that can lower the color effect visibility thresh-
old and improve sensitivity for the weak flow in tissues.
US is cheaper and easier to operate than MR imaging;
however, there have only been a few studies about the
evaluation of synovial vascularity in arthritis using sonic
contrast agent-enhanced US.
The purpose of this study is to validate contrast-
enhanced PD US for evaluation of synovial vascularity in
experimentally induced knee arthritis in rabbits by
comparing PD US with MR and histologic findings.
MATERIALS AND METHODS
The study was approved by the institutional Committee
on Animal Research. Arthritis was induced in the left knee
of 13 white New Zealand rabbits (mean weight, 3 Kg).
Carrageenin (Sigma, C1867), a mucopolysaccharide, has
been used to generate inflammatory arthritis in animal
models (13 17). As carrageenin provokes a local antigenic
inflammatory response, intra-articular injection of
carrageenin resembles the pathologic features seen in
rheumatoid arthritis (18 20). After shaving the anterior
knee, 0.3 ml of 2% (w/v) carrageenin was injected into the
left knee twice using a 26-gauge needle at a one-week
injection interval. The right knee of the rabbit was used as
the control knee.
Power Doppler US (ATL 3000, 5-12 MHz linear
transducer, Bothell, WA), first without and then with a
sonic contrast agent (Levovist, Schering, Berlin, Germany)
injection via an ear vein, was performed seven days after
the second intra-articular injection of carrageenin. During
the imaging procedures, rabbits were anesthetized with
ketamine (35 mg/kg) and xylazine (5 mg/kg) injected
intramuscularly. US was performed by a musculoskeletal
radiologist. With the rabbit in the lateral decubitus
position, posterior joint spaces were evaluated as they
were more accessible than anterior joint spaces. The
imaging plane and machine settings (55 dB dynamic range,
medium persistence, medium frame rate, low wall filter,
1,000 Hz pulse repetition frequency, flow optimization:
medium vein, 50 70% CPA) were identical throughout
all US examinations. The sonic contrast agent was
prepared in a standard manner. Over 5 seconds, 0.5 mL of
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Fig. 1. Ultrasound images of carrageenin-induced arthritis of the rabbit. 
A, B. Power Doppler ultrasound examinations before (A) and after (B) ultrasound contrast injection in the arthritic left knee show
expansion of the joint capsule and heterogeneous echogenicity in the posterior joint space (arrow in A). Power Doppler signals in the
joint are faintly visible before contrast agent injection, except for the penetrating intraosseous signal (score = 0.45 mm2). After the
contrast agent injection, Power Doppler signals increase in extent in the posterior joint space (double arrows in B) and signals of
popliteal vessels (arrowheads in B) appear prominently (score = 30.78 mm2).
A B
sonic contrast was slowly infused at a concentration of 200
mg/ml. The arthritic left knees were assessed first, followed
by evaluation of control knees. Areas of highest vascular-
ity were selected for both knees. The arthritic knee was
then evaluated with sonic contrast agent under the same
US parameters (Fig. 1). Five minutes after completing the
left knee, the right knee was evaluated at the same
location as the pre-contrast scanning slice with repeated
injection of the contrast agent (Fig. 2). 
MR imaging was performed on a 1.5T MR scanner
(Signa, General Electric, Milwaukee, WI) using bilateral
TMJ coil (GE, Milwaukee, WI) immediately after US. The
images were acquired in the sagittal plane using the follow-
ing three pulse sequences: T1-weighted spin echo (TR/TE =
600/14, 8 cm FOV, 3 mm slice thickness with no gap, 256
256 matrix, 1 NEX); fat-suppressed T2-weighted fast
spin echo (TR/TE = 4000/68, 8 cm field-of-view [FOV], 3
mm slice thickness with no gap, 256 256 matrix, 2 NEX,
8 echo train length); and pre- and post-gadolinium-
enhanced three-dimensional fat-suppressed, fast spoiled
gradient echo (3D FS-FSPGR; TR/TE = 21.8/2.8, 20 flip
angle, 256 192 matrix, 8-10 FOV, 2 mm slice thickness
with no gap, 2 NEX, 5 minute 2 second acquisition time,
0.1 mmol/kg of Gd-DTPA [Magnevist, Schering, Berlin,
Germany]).
Pre- and post-contrast PD images were assessed by
analyzing the color pixel areas using a free software
program called Computer-aided Image Analysis (Sonic,
Seoul, Korea). This software allows manual segmentation
to determine the areas of PD signals in the FOV; a
musculoskeletal radiologist oversaw all processing.  
MR contrast enhancement was assessed in pre- and post-
contrast 3D FS-FSPGR images. High signal change in the
knee joint was regarded as enhancement. Intra-articular
enhancement was graded at each knee joint: grade 1,
enhancement of less than one-third of the knee joint area;
grade 2, one-third to two-thirds enhancement; and grade 3,
more than two-thirds enhancement. 
After all US and MR examinations, the rabbits were
killed with an overdose of ketamine and xylazine. Both
hind legs were immediately removed and the knee joints
were fixed in phosphate-buffered formalin after dissection
and decalcification. Hematoxylin and eosin staining and
immunohistochemical staining for CD31 antigen were
performed, and histologic evaluations were taken. Anti-
CD31 antibody (JC/70A, DAKO, Glostup, Denmark)
staining was done using the LSAB method (Dako LSAB
kit: Glostup, Denmark). The microvessel density (MVD) in
each joint was regarded as the number of vessels in five
different microscopic fields ( 400) that presumably had
high MVD areas.
Results were analyzed statistically using Wilcoxon
Signed Rank test for pre- and post-contrast agent injection
images, Mann-Whitney test for arthritic and control knees,
and Spearman’s correlation test for MVD and other
parameters using SPSS 10.0 (SPSS Inc., Chicago, IL).
RESULTS
Ultrasonography of all arthritic left knees showed
expansion of the joint capsule compared with control knee.
Heterogeneous echogenicity in the posterior recess was
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Fig. 2. Ultrasound images of control right knee of the rabbit. 
A, B. Power Doppler ultrasound examinations before (A) and after (B) ultrasound contrast agent injection in the control knee show faint
power Doppler signals of the posterior joint space (arrow in A) before contrast agent injection (score = 0.74 mm2) and a few intra-articular
signals (double arrows in B) after contrast enhancement (score = 2.57 mm2).
A B
demonstrated in all arthritic knees and there were no
anechoic lesions; these echogenicities were more sugges-
tive of debris or inflammatory tissues than pure joint
effusion (Fig. 1). Bony abnormality was not observed on
the surface of the femur or the tibia. Control knees had
grossly normal US features (Fig. 2): the joint capsule was
not distended, and no effusion or synovial proliferation
was detected.
When the PD US was performed before and after sonic
contrast-agent injection, the color pixel areas were
increased after contrast injection. The mean color pixel
areas changed from 4.37 (1.11 8.54) mm2 to 16.42 (9.42
30.78) mm2 in the arthritic knee (p < 0.05), whereas it
changed from 0.77 (0 2.38) to 3.13 (1.44 7.56) mm2 in
the control knee (p < 0.05). The arthritic knee had more PD
signal than the control knee both before and after contrast
administration (Table 1). The differences in the scores
between the pre- and post-contrast images of the arthritic
knee were 12.05 (4.1 30.33) and 2.36 (0.23 7.56) in the
control knee; the arthritic knee had more significant
contrast enhancement than the control knee (p < 0.01). In
MR grading of arthritic knees, five were grade 2 and eight
were grade 3 (Fig. 3). All control knees were grade 1 (Fig.
4). MVD and PD US revealed no significant difference
between grade 2 and 3 in arthritic knees (p > 0.05).
Histopathology revealed synovial hypertrophy and
aggregation of foamy macrophages in the subsynovial
layer of arthritic knee (Fig. 5). The average MVD in
arthritic knees was 88 (54 129) and 46 in control knees
(39 62) (Fig. 6). The MVD only correlated with the color
pixel areas of contrast-enhanced PD imaging in the
arthritic knees (p < 0.05). 
DISCUSSION
Early diagnosis of inflammatory arthritis is important
Lee et al.
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Table 1. Mean Areas (mm2) of Power Doppler Signals in
Arthritic Knees and Control Knees of the Rabbit 
Arthritic Knee Control Knee p-value
On pre-contrast images 04.37 0.77 < 0.05
On post-contrast images 16.42 3.13 < 0.05
Difference between them 12.05 2.36 < 0.01
Fig. 3. MR images of carrageenin-
induced arthritis of the rabbit. 
Sagittal scan of T1-weighted image (A),
fat-suppressed, fast spin-echo T2-
weighted image (B), three-dimensional
fat-suppressed, fast spoiled gradient-
echo (3D FS-FSPGR) image before
contrast enhancement (C), and 3D FS-
FSPGR image after contrast enhance-
ment (D) show joint effusion with
posterior joint capsular distension (arrow
in A and B) and thick contrast enhance-
ment at the posterior margin of the joint
space on the 3D FS-FSPGR image
(arrowhead in D, grade 2).
A B
C D
because early, aggressive treatment may reduce long-term
disability (21). For early detection of synovial inflamma-
tory changes on conventional radiography (22 27),
clinical examination and laboratory tests are limited in
their usefulness (28, 29). Recently, MRI and US have
improved the sensitivity for early detection of RA (11, 12).
Synovial Vascularity Quantification Using Contrast-Enhanced Power Doppler US
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Fig. 4. MR images of the control right
knee of the rabbit. 
Sagittal scan of T1-weighted image (A),
fat-suppressed, fast spin-echo T2-
weighted image (B), three-dimensional
fat-suppressed, fast spoiled gradient
echo (3D FS-FSPGR) image before
contrast enhancement (C), and 3D FS-
FSPGR image after contrast enhance-
ment (D) show no abnormal intra-articu-
lar lesions. Note the prominent intra-
articular fat on T1WI (arrow in A), a few
high signals on T2WI (double arrows in
B), and little contrast enhancement on
3D FS-FSPGR image (arrowhead in D,
grade 1).
A B
C D
Fig. 5. Histology (Hematoxylin & Eosin staining, 100) 
A. Arthritic knee shows marked synovial hypertrophy (arrow) and aggregation of foamy macrophages and lymphocytes in the subsyn-
ovial layer.
B. Control knee shows an intact synovial membrane without hypertrophy (double arrows).
A B
Hyperplastic and locally invasive synovia, inflammatory
infiltrates, fibroblast proliferation, and intense neovascular-
ization are common histological findings of RA. MRI
provides useful information on soft tissue changes, bone
destruction (erosion), bone marrow edema, and joint
effusion; it also contributes to the evaluation of prognosis
for RA (5, 30, 31). Although MRI is a powerful tool for the
evaluation of synovitis with easy detection of synovial
hypertrophy with contrast administration, the high costs,
long examination times, and limited evaluation of only one
anatomic lesion at a time may restrict the use of MRI for
the evaluation of RA, especially in follow-up examinations
(5, 11).
US is also considered a promising tool for detecting
morphological changes in RA. It can detect synovial
changes earlier, even in asymptomatic arthritis (1, 32), and
it can reveal bone erosion, although the sound can not
penetrate the cortex (12, 33). US may be superior to
conventional radiography or MRI in certain situations, for
instance, detection of small bone erosions (34). So, US has
been often used as a complementary tool in the clinic to
evaluate high-risk patients with inflammatory arthritis who
do not have abnormalities on radiography (34). 
Vascularization and angiogenesis develop in the pannus
of RA because blood vessels are needed to recruit
leukocytes or to provide nutrients and oxygen to starved
tissue (35). Weber and De Bandt suggested that endothelial
cell proliferation might be the inciting factor, and that
persistent angiogenesis was a major factor in the chronicity
of rheumatoid synovitis (36). With advances in MRI and
US, much concern has been given to assessing angiogenesis
and vascularity of RA.
With PD US, in particular, it is possible to assess the
vascularity of synovitis (7). PD US correlates with histolog-
ical findings in RA, proving its validity for qualitative
evaluation of RA (37). However, PD is limited in its ability
to detect slowly flowing vessels and small vessels. To
improve the signal from weak tumor vascularity, the use of
an US contrast agent was introduced. In a few recent
studies, US contrast agent has been used for synovitis and
proved to be useful for evaluating synovial vascularity (38,
39). The US contrast agent improved the echo enhance-
ment from synovial vessels, which correlated with MRI
data (38) and clinical grouping (39). However, these
studies were designed for qualitative assessment. In
contrast to previous studies, our study quantitatively
measured the synovial vessels through computer-aided
color-pixel counting. The use of an US contrast agent
significantly increased the vascular signal areas in both
arthritic and control knees. Moreover, it also increased the
vascular yield in arthritic knees more than in control knees.
When compared with control knees and correlated with
MRI and MVD data, quantitative evaluation of PD US
using a contrast agent allowed for the evaluation of
synovial vascularity in cases of synovitis. Szkudlarek et al.
(40) reported that contrast-enhanced PD US at the
metacarpophalangeal joints did not increase the sensitivity
for detecting rheumatoid arthritis; all six patients who did
not have pre-contrast PD signal also did not show PD
signal after US contrast agent administration. However,
Klauser et al. (39) demonstrated that contrast agent
administration significantly improved the detection of
color flow signals in the finger joints of patients with RA.
Fiocco et al. (41) reported that contrast-enhanced PD US
Lee et al.
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Fig. 6. Immunohistochemical staining for CD 31.
A. Arthritic knee shows many vessels in synovial and subsynovial layers (in brown). 
B. Control knee shows a few vessels in synovial and subsynovial layers. 
A B
in knee joints was more useful than the unenhanced PD
US, showing higher sensitivity and more reproducible PD
signal scores. In our study, all arthritic knees had PD
signals. Even in control knees, the three that did not have
pre-contrast power Doppler signal manifested post-contrast
PD signal. Szkudlarek et al. (40) did not correlate their
data with histologic findings, whereas Fiocco et al. (41)
performed arthroscopic correlation, and histological
correlation was done in our study. MVDs of the joint only
correlated with post-enhancement PD US images in
arthritic knee. Thus, post-contrast enhancement PD US
images are important for evaluating angiogenesis. 
The variable results of studies using US contrast agent
are thought to be due to differences in joint size, numbers
of examinations, selection criteria, Doppler techniques,
and joint diseases (42). The depth of the target area in
Doppler examination is also important because the
sensitivity is affected by penetration depth of lowest
detectable velocity (43). Human knee joint is deeper than
superficial joints, so the detection of PD or color Doppler
signals in the knee joint will be lower than that in hand and
finger joints. And the curved or linear transducers used in
many US scanners had different Doppler performance
(43). Variation of vascularity in each joint might also affect
the results. Thus, further controlled evaluations will be
required to assess the usefulness of the contrast-enhanced
PD US. 
In our study, contrast-enhanced US is superior to MR for
the evaluation of synovial vascularity as an indicator of
synovitis. Many studies have evaluated MR and color
Doppler or PD US in rheumatoid arthritis; some reveal
comparable results with MR and US (38, 44, 45), whereas
some are superior at US (46) or at MR evaluation (47).
Magarelli et al. (38), Backhaus et al. (46), and Wamser et
al. (47) studied contrast-enhanced PD US and MRI for the
evaluation of synovitis, but reported different results.
Backhaus et al. (46) reported that contrast-enhanced US
was more sensitive than MRI in the detection of synovitis
and tenosynovitis. In contrast, contrast-enhanced US was
not as sensitive as MR in the study by Wamser et al. (47),
where they evaluated four anatomic locations of the
shoulder joint with a single bolus injection. However, the
time of evaluation in contrast-enhanced PD US with
Levovist is limited because of rapid destruction of
microbubbles at high mechanical index, which decreases
signal intensity with time (48). As a result, evaluation of
multiple anatomic locations with a single contrast injection
might decrease the sensitivity for microbubble detection.
To overcome this problem, repeated injection of US
contrast agent can be applied, as in our study, and continu-
ous or slow infusion of US contrast agent (9, 49) and
application of third generation of US contrast agents (50,
51) can also help. 
US contrast agent has the potential to act as a macromol-
ecular agent that could evaluate the perfusion and
hemodynamics of soft tissues or tumors. The mean molecu-
lar diameter of Levovist is large, approximately 3 m (50),
and no extravasation into the surrounding tissue was
demonstrated (52), which indicates that Levovist acts as a
true intravascular contrast agent. Contrast-enhanced MR
imaging may also provide information on vascular
perfusion and permeability (53, 54). However, the MR
contrast agent Gd-DTPA is easily extravasated and is not a
true intravascular agent (55). 
MR evaluation of synovial vascularity in our arthritic
model was based on assessing the enhancement region.
Enhancement grading is not a quantitative method, but a
semi-quantitative method. This could be the reason why
MR evaluation correlated less with PD US and histological
evaluation. Dynamic evaluation of synovitis would better
correlate with histologic evaluation, as shown in inflamma-
tory arthritis (30). Thus, more elaborate MRI techniques
are required for the evaluation of synovitis.
The use of a sonic contrast agent has some limitations,
i.e., the blooming artifact after injection, signal changes
due to patient movement, restricted scanning time because
PD US detects the destroyed microbubbles, increase in
systolic peak velocity, and high-intensity transient signals
(38, 50). Recently, new US contrast agents have been
introduced for low mechanical index imaging and for
relatively longer examination times (50, 51).
In summary, contrast-enhanced PD US helps quantify
and detect synovial inflammation in the arthritic knee
model of the rabbit by showing increased PD signal
compared to the pre-contrast imaging of the arthritic knee
and the post-contrast imaging of the control knee. 
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